Skip to main content

Table 1 Study Calendar (SABR + Xofigo arm)

From: A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us